Board Decisions

GF/B09/DP16

Approved by the Board on: 19 November 2004

Continuity of Services

Decision Point 1

The Board adopts the following system for addressing continuity of services in the context of the Phase 2 renewal decision:

1. A recipient (typically a CCM) whose Request for Continued Funding is not approved may submit an Extra-ordinary Request for Continued Funding for Treatment.
2. The Extra-ordinary Request will be limited to expenses directly related to the continuation of treatment (including medicines [which, in the case of discontinuation of antiretroviral therapy, includes drugs for HIV-related opportunistic infections], diagnostics, and, as appropriate, costs for medical staff and other personnel directly involved in care of the patients on treatment) for those people already placed on life-long treatment under the existing proposal at the time of the Extra-ordinary Request.
3. The Extra-ordinary Request will be limited to the amount required to provide services directly related to the continuation of treatment for one year from the date of submission of the Extra-ordinary Request, less the amount granted under the Phase 1 proposal not disbursed at the time of the Extra-ordinary Request.
4. In addition to a budget, the Extra-ordinary Request shall contain a description of the steps that are being taken to find sustainable sources of financing for the people on treatment, and to ensure that treatment is being delivered effectively.
5. The Secretariat will review these plans for sustainable financing and the budget, and provide a recommendation to the Board on their appropriateness. The Extra-ordinary Request will not be subject to a performance-based review unless the Secretariat has pre-existing information to suggest that the approach to care and/or quality of care was inadequate. The frequency and modality for the provision of the Secretariat's recommendations, and the mechanism by which funds are committed to the Extra-ordinary Requests will be in line with the decision that the Board adopts for the broader Phase 2 decision-making process.
6. Throughout the process, the Secretariat will actively engage with technical partners to identify mechanisms to ensure continuity of services.

There are no material budgetary implications for this decision point.

Decision Point 2

The Board asks the Secretariat to explore with key partners (including WHO, UNAIDS, the World Bank, bilateral agencies, recipients, non-governmental organizations, and people living with the three diseases) a process that will result in long-term solutions to the issues of continuity of treatment, care and support, and prevention services for HIV/AIDS, tuberculosis, and malaria. The Secretariat should report back to the PMPC on the process before the Tenth Board Meeting. The Secretariat should report back to the Board through the PMPC on potential solutions in time for the Eleventh Board Meeting.

Budgetary implications: The additional cost of implementing this recommendation is estimated at $90,000.

Budgetary Implications

The additional cost of implementing this recommendation is estimated at $90,000.